Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade.
about
Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT.MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma.Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma.Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.Molecular Pathogenesis of Hepatocellular Carcinoma.The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.Chemical and genetic inhibition of STAT3 sensitizes hepatocellular carcinoma cells to sorafenib induced cell death.ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
P2860
Q36847307-881BC547-63BD-4CBB-8CC2-8CD72566B07DQ37317467-7B56E9EB-5D71-41E0-9942-CE7E14418C9DQ37666880-44433913-FE00-40E8-A859-8EED130EBE8CQ37694839-F58A6B91-9D21-464D-9BFE-737DEC8B354EQ37744990-134E351C-9B1D-4321-8BB4-E2CF9D655D51Q38702281-3152B834-CBCF-4499-A234-4205D80F0B0CQ41241610-62ED34D3-2DBA-4221-B84C-9D5D67983590Q41544729-BA5F4E47-827D-4155-9885-66A190EA9ED8Q48300748-A9542979-85C4-4345-8B68-D7D6F2B8F722Q55180385-80C9EB4C-70A5-4B08-A4E2-78415F536D17Q58699475-D019AA71-7B01-45C7-858F-E4B8F5305E42
P2860
Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sorafenib enriches epithelial ...... noma through TSC2-AKT cascade.
@en
type
label
Sorafenib enriches epithelial ...... noma through TSC2-AKT cascade.
@en
prefLabel
Sorafenib enriches epithelial ...... noma through TSC2-AKT cascade.
@en
P2093
P2860
P356
P1433
P1476
Sorafenib enriches epithelial ...... noma through TSC2-AKT cascade.
@en
P2093
Dong-Xian Guan
Er-Bin Zhang
H Phillip Koeffler
Jiang-Sha Zhao
Jing-Jing Li
Ling-Yun Long
Shu-qun Cheng
P2860
P304
P356
10.1002/HEP.28117
P407
P577
2015-08-07T00:00:00Z